La Jolla Pharmaceutical Company to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) today announced that Deirdre Y. Gillespie, M.D., President and Chief Executive Officer, will present on Monday, February 9, at 11:00 a.m. Eastern Time during the BIO CEO Investor Conference. The conference will take place at The Waldorf=Astoria Hotel in New York City. An audio web cast of the presentation will be available through the Company’s Web site: http://www.ljpc.com.

MORE ON THIS TOPIC